North America Chronic Kidney Disease Drug Market to Report Greater Rise Than Other Regional Markets
The global chronic kidney disease drugs market is largely fragmented, states a research report by Transparency Market Research (TMR). The top four players, namely Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for a share of only 41.4% in this market in 2015.
View full press release